Cliff Asness's TNGX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 82,233 shares of Tango Therapeutics, Inc. (TNGX) worth $728,584, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in TNGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 142,108 shares. Largest reduction occurred in Q2 2025, reducing 63,162 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Tango Therapeutics (TNGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tango Therapeutics (TNGX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +3,058 | Add 3.86% | 82,233 | $8.86 |
| Q3 2025 | +229 | Add 0.29% | 79,175 | $8.40 |
| Q2 2025 | -63,162 | Reduce 44.45% | 78,946 | $5.12 |
| Q1 2025 | +142,108 | New Buy | 142,108 | $1.37 |
| Q4 2024 | -14,206 | Sold Out | 0 | $0.00 |
| Q3 2024 | -6,445 | Reduce 31.21% | 14,206 | $7.70 |
| Q2 2024 | -30,323 | Reduce 59.49% | 20,651 | $8.58 |
| Q1 2024 | +28,798 | Add 129.86% | 50,974 | $7.94 |
| Q4 2023 | +22,176 | New Buy | 22,176 | $9.90 |
| Q4 2022 | -22,030 | Sold Out | 0 | $0.00 |
| Q3 2022 | +22,030 | New Buy | 22,030 | $3.63 |
Cliff Asness's Tango Therapeutics Investment FAQs
Cliff Asness first purchased Tango Therapeutics, Inc. (TNGX) in Q3 2022, acquiring 22,030 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Tango Therapeutics, Inc. (TNGX) for 11 quarters since Q3 2022.
Cliff Asness's largest addition to Tango Therapeutics, Inc. (TNGX) was in Q1 2025, adding 142,108 shares worth $194,688.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 82,233 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $728,584.
As of the Q4 2025 filing, Tango Therapeutics, Inc. (TNGX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Tango Therapeutics, Inc. (TNGX) was 142,108 shares, as reported at the end of Q1 2025.